Anish Suri

Title: Anish Suri: Innovator in Antibody Research

Introduction

Anish Suri is a notable inventor based in Beerse, Belgium. He has made significant contributions to the field of biotechnology, particularly in the development of antibodies. With a total of 2 patents, Suri's work focuses on innovative solutions that have the potential to impact therapeutic applications.

Latest Patents

Suri's latest patents include groundbreaking inventions related to nucleic acids encoding anti-CD154 antibodies. The first patent describes antagonistic antibodies that specifically bind to CD154, along with polynucleotides encoding these antibodies or their fragments. The second patent also pertains to anti-CD154 antibodies and outlines methods for making and using these innovative solutions. Both patents highlight Suri's commitment to advancing medical science through his research.

Career Highlights

Anish Suri is currently employed at Janssen Biotech, Inc., where he continues to push the boundaries of antibody research. His work at this esteemed company allows him to collaborate with other experts in the field and contribute to the development of new therapeutic strategies.

Collaborations

Some of Suri's notable coworkers include Johan Fransson and Galina Obmolova. Their collaboration fosters a dynamic environment for innovation and research, enhancing the potential for groundbreaking discoveries in biotechnology.

Conclusion

Anish Suri's contributions to the field of antibody research exemplify the spirit of innovation in biotechnology. His patents and work at Janssen Biotech, Inc. reflect a dedication to advancing medical science and improving therapeutic options.